TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INTUNIV

Did you know this trademark is already registered in Brazil?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Registro de marca em vigorType: WordOffice: Brazil

Quick snapshot

INTUNIV

ST13

BR500000830952004

Class

5

Filing

830952004

Registration

830952004

Progress at the INPI

  1. Filing03/04/11
  2. Publication08/02/11
  3. Examination
  4. Allowance04/01/14
  5. Grant07/08/14
  6. In force07/08/34

The registration was granted on 07/08/2014 and is in force until 07/08/2034, when it must be renewed.

Protection valid until:07/08/2034

AlertaMarcas

Get a Monitoring proposal

Monitoring is a paid weekly follow-up service: we analyze similar marks with every RPI issue, flag threats and deadlines, and give you access to a portal. We send the proposal by email.

We use your details only to send the proposal.

Latest action published by the INPI: 05/28/2024. We update with every new RPI gazette, published weekly.

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

INPI status

Registro de marca em vigor

Case type

Application and registration

Recorded events

7

Latest update

05/28/2024

Trademark type

Word

Nice classes

5

Filing date

03/04/2011

Registration date

07/08/2014

Expiration date

07/08/2034

Complete case details

Structured fields from the responsible authority and the official record.

Nature

De Produto

Responsible office

Brazil

Owner type

NÃO RESIDENTE

Owner location

CH

Holders and representatives

Holders

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

Representatives

Dannemann SiemsenVer perfil do escritório

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Preparações farmacêuticas para o tratamento de distúrbios do sistema nervoso central

Publications

History of INPI decisions and trademark events.

7 publications found

IPAS270

Deferimento da petição

Protocolo: 800240144397 (26/04/2024) Petição (tipo): Prorrogação de registro de marca e expedição de certificado no prazo ordinário (374.5) Titular(es): TAKEDA PHARMACEUTICALS INTERNATIONAL AG Procurador: Dannemann Siemsen Advogados

RPI 2786

05/28/2024

IPAS270

Deferimento da petição

Protocolo: 850230134712 (24/03/2023) Petição (tipo): Anotação de transferência de titularidade decorrente de cessão (349.1) Requerente: TAKEDA PHARMACEUTICALS INTERNATIONAL AG Procurador: Dannemann, Siemsen, Bigler & Ipanema Moreira Cedente: Shire Pharmaceuticals Ireland Limited [IE] Cessionário: TAKEDA PHARMACEUTICALS INTERNATIONAL AG

RPI 2732

05/16/2023

IPAS270

Deferimento da petição

Protocolo: 850230134584 (24/03/2023) Petição (tipo): Anotação de alteração de nome, sede ou endereço (348.3) Requerente: SHIRE PHARMACEUTICALS IRELAND LIMITED Procurador: Dannemann, Siemsen, Bigler & Ipanema Moreira Detalhes do despacho:SEDE ALTERADA.

RPI 2728

04/18/2023

IPAS566

Petição de retificação atendida

Protocolo: 850190184573 (14/06/2019) Petição (tipo): Retificação por erro de publicação na RPI [em processo de registro] (366.3) Titular(es): SHIRE PHARMACEUTICALS IRELAND LIMITED Procurador: Dannemann, Siemsen, Bigler & Ipanema Moreira Detalhes do despacho:O endereço do titular foi corrigido.

RPI 2566

03/10/2020

IPAS158

Concessão de registro

RPI 2270

07/08/2014

IPAS029

Deferimento do pedido

RPI 2256

04/01/2014

003

PUBLICADO o pedido de registro, de acordo com o Art. 158 da LPI.

RPI 2117

08/02/2011

TAKEDA PHARMACEUTICALS INTERNATIONAL AG also protects technology and design at the INPI

3 patent applications under the same owner.

Related trademarks

Continuous trademark protection

Get notified about every new filing that threatens INTUNIV or your mark.

Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.